About six months ago I had peripheral blood drawn for Invitae's next GEN germline mutations and testing. (Advanced metastatic hormone sensitive prostate cancer) The results came back positive for two germline mutations:
RET and BRCA2. Both mutations were described as having "unknown significance" and we were told that neither were pathological mutations. Well… We know for sure that BRCA2 is definitely a pathological mutation and we understand the implications of that(DDR mutation, heterogeneous cancer, much more aggressive disease, eligible for PARP inhibitors) . My question is: why do they consider BRCA2 to be of unknown significance and what is the significance of RET Germline mutation for advanced prostate cancer? Does germline RET mutation predispose cancer cells to NEPC transition?
Written by
Farmhand
To view profiles and participate in discussions please or .
Where did you hear that germline RET mutation predisposes cancer cells to NEPC? Not all BRCA2 mutations are alike- it depends which BRCA2 mutation it is.
I was only guessing about the RET mutation… Comparing it to RET mutation and MEN2 ...hopefully I am wrong and there is no significance?I will read the report more closely for details of BRCA2. Are there particular details that I should be looking for as to that type of BRCA2?
The above screenshot is a copy of the test results. Our oncologist interpreted the BRCA2 mutation as a legitimate pathological mutation as several family members have breast cancer.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.